Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New methods needed for preclinical tests, scientists say
rat
"Research and development effort is often wasted because of the poor reliability of animal-based methods."
Calls for non-animal models following publication of a new scientific paper

FRAME - the Fund for the Replacement of Animals in Medical Experiments - is calling for more collaboration between organisations, government and the pharmaceutical industry following a new investigation of preclinical drug trials.

Scientific papers covering more than 2,300 substances that were tested on rats, mice and rabbits were analysed to measure the likelihood that chemicals showing no adverse reactions in trials using laboratory animals would behave the same way in humans.

The results, says director of FRAME Alternatives Laboratory Dr Andrew Bennett, suggest large numbers of compounds that are functional in animals show little potency in humans, while others that show no adverse reactions in animals later prove harmful in human trials.

Dr Bennett says the paper, published in FRAME's scientific journal ATLA, highlights the need for more relevant non-animal tests but he believes they can only be found if all those involved work together to look for them.

"Toxicity data from animal studies can be seriously misleading but it is no good just saying that animal tests don't work - we have to find methods that can identify potential risks and benefits. There are major issues for companies in the pharmaceutical sector. Research and development effort is often wasted because of the poor reliability of animal-based methods. If we are to find useful, safe drugs in the future it is vital that all interested parties work together to find valid, non-animal methods that will identify them."

Preclinical tests require the use of two species, usually one rodent (rat or mouse) and one non-rodent (often dogs) before drugs enter clinical trials in humans. The second species is intended to identify those substances harmful to humans that were missed by the rodent tests.

This latest study was carried out by the same team who investigated the use of dogs in human drugs tests last year, that concluded that animal results are inconsistent. The latest statistical analysis of results from rats, mice and rabbits supported those findings, although it is in part to be expected as drugs now being developed are increasingly aimed at specific human cell responses.

FRAME was established in 1969 to promote the concept of alternatives to laboratory animal use in medical research and toxicity testing. The charity is dedicated to developing and validating alternative methods, and working actively with all interested parties.

Become a member or log in to add this story to your CPD history

Reporting service for dead wild birds updated

News Story 1
 The Animal and Plant Health Agency (APHA) has updated its online reporting service for dead wild birds.

The new version allows those reporting a dead bird to drop a pin on a map when reporting the location. It also includes a wider range of wild bird species groups to select from when describing the bird.

The online service, which helps APHA to monitor the spread of diseases such as avian influenza, can be accessed here

Click here for more...
News Shorts
NI chief vet urges bluetongue vigilance

Northern Ireland's chief veterinary officer (CVO) has urged farmers to be vigilant for signs of bluetongue, after the Animal and Plant Health Agency warned there was a very high probability of further cases in Great Britain.

There have been 126 confirmed cases of bluetongue virus serotype 3 in England since November 2023, with no cases reported in Northern Ireland. The movement of live ruminants from Great Britain to Northern Ireland is currently suspended.

According to the Department of Agriculture, Environment and Rural Affairs (DAERA), the virus is most likely to enter Northern Ireland through infected animals or germplasm (semen or ova) being imported.

Brian Dooher, Northern Ireland's CVO, said: "Surveillance for this disease within Northern Ireland has been increased to assist with detection at the earliest opportunity which will facilitate more effective control measures."

Farmers should report any suspicions of the disease to their private veterinary practitioner, the DAERA Helpline on 0300 200 7840 or their local DAERA Direct Veterinary Office.